The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Metoject 15 mg solution for injection in pre-filled pen

IMED Healthcare Ltd.PPA1463/172/003

Main Information

Trade NameMetoject 15 mg solution for injection in pre-filled pen
Active SubstancesMethotrexate
Dosage FormSolution for injection in pre-filled pen
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/172/003

Group Information

ATC CodeL01BA Folic acid analogues
L01BA01 methotrexate


License statusAuthorised
Licence Issued10/09/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back